|

Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma.

RECRUITINGN/ASponsored by Spine Centre of Southern Denmark
Actively Recruiting
PhaseN/A
SponsorSpine Centre of Southern Denmark
Started2021-03-29
Est. completion2025-07-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04533217

Summary

Patients with newly diagnosed or known multiple myeloma with newly diagnosed vertebral lesion(s) will be invited to participate in a cross-sectoral randomized controlled trial. The trial will compare two groups of patients which either receive regular medical treatment of their vertebral lesion(s) or vertebroplasty in addition to regular medical treatment. Our goal is to investigate the effectiveness of vertebroplasty and determine the role of surgical treatment in the overall treatment of patients with multiple myeloma and vertebral lesion(s).

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* known multiple myeloma
* verified lesion(s) between Th6-L5
* 4 or less fractures
* relevant pain in 3 months or less
* vertebroplasty can be performed in one procedure
* VAS 5 or more

Exclusion Criteria:

* presence of neurologic deficit
* psychological or psychiatric disorder hat is expected to interfere with compliance

Conditions3

CancerMultiple MyelomaVertebral Fracture

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.